Last updated: 17 July 2019 at 5:42pm EST

Capital Group, Lpluxor Capi... Net Worth




The estimated Net Worth of Capital Group, Lpluxor Capi... is at least $71.3 Million dollars as of 6 October 2014. Capital Capi owns over 2,472 units of Arcturus Therapeutics Inc stock worth over $585,132 and over the last 12 years Capital sold ARCT stock worth over $70,687,500.

Capital Capi ARCT stock SEC Form 4 insiders trading

Capital has made over 7 trades of the Arcturus Therapeutics Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Capital bought 2,472 units of ARCT stock worth $1,664,200 on 6 October 2014.

The largest trade Capital's ever made was selling 2,827,500 units of Arcturus Therapeutics Inc stock on 21 May 2013 worth over $70,687,500. On average, Capital trades about 396,303 units every 63 days since 2013. As of 6 October 2014 Capital still owns at least 27,890 units of Arcturus Therapeutics Inc stock.

You can see the complete history of Capital Capi stock trades at the bottom of the page.



Insiders trading at Arcturus Therapeutics Inc

Over the last 12 years, insiders at Arcturus Therapeutics Inc have traded over $137,035,874 worth of Arcturus Therapeutics Inc stock and bought 56,234 units worth $767,374 . The most active insiders traders include William M Kahane, Nicholas S Schorsch, and Peter C Farrell. On average, Arcturus Therapeutics Inc executives and independent directors trade stock every 33 days with the average trade being worth of $1,034,818. The most recent stock trade was executed by Jing L. Marantz on 14 June 2024, trading 3,131 units of ARCT stock currently worth $65,688.



What does Arcturus Therapeutics Inc do?

founded in 2013 and based in san diego, calif., arcturus therapeutics is poised to become an industry leader in the application of rnai technologies for the treatment of disease and improved quality of life. the company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. backed by a management team with extensive experience in the discovery and development of therapeutic modalities, arcturus is on the forefront of research and development of nanoparticle sirna drug delivery systems.



What does Arcturus Therapeutics Inc's logo look like?

Arcturus Therapeutics Holdings Inc logo

Complete history of Capital Capi stock trades at BJ`s Restaurant, Altisource Asset Management Corp, and Arcturus Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
6 Oct 2014 Capital Group, Lpluxor Capi...
Buy 2,472 $673.22 $1,664,200
6 Oct 2014
27,890
27 Aug 2014 Capital Group, Lpluxor Capi...
Buy 2,841 $700.60 $1,990,405
27 Aug 2014
26,878
25 Aug 2014 Capital Group, Lpluxor Capi...
Buy 13,043 $682.05 $8,895,978
25 Aug 2014
26,608
21 May 2014 Capital Group, Lpluxor Capi...
Buy 15,630 $943.10 $14,740,653
21 May 2014
3,821
15 May 2014 Capital Group, Lpluxor Capi...
Buy 8,935 $834.88 $7,459,653
15 May 2014
2,966
30 Jul 2014 Capital Group, Lpluxor Capi...
Buy 300,000 $34.25 $10,275,000
30 Jul 2014
142,568


Arcturus Therapeutics Inc executives and stock owners

Arcturus Therapeutics Inc executives and other stock owners filed with the SEC include: